Azidah Abdul Kadir

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Psychometric Properties

Cross Sectional

Top Venues

International journal of environmental research and public health

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Siti Nur Aisyah Zaid, Azidah Abdul Kadir, Norhayati Mohd Noor, Basaruddin Ahmad, Muhamad Saiful Bahri Yusoff, Anis Safura Ramli, Jasy Liew Suet Yan
Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia. PloS one 19 (4) (2024)
Siti Nur Aisyah Zaid, Azidah Abdul Kadir, Norhayati Mohd Noor, Basaruddin Ahmad, Muhamad Saiful Bahri Yusoff, Anis Safura Ramli, Jasy Liew Suet Yan
Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia. PloS one 19 (4) (2024)
Siti Nur Aisyah Zaid, Azidah Abdul Kadir, Norhayati Mohd Noor, Basaruddin Ahmad, Muhamad Saiful Bahri Yusoff, Anis Safura Ramli, Jasy Liew Suet Yan
Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia. PloS one 19 (4) (2024)
Ahmad Faiq Mukhtar, Azidah Abdul Kadir, Norhayati Mohd Noor, Ahmad Hazim Mohammad
Knowledge and Attitude on Childhood Vaccination among Healthcare Workers in Hospital Universiti Sains Malaysia. Vaccines 10 (7) (2022)
Atirah Az-Zahra Abu Bakar, Azidah Abdul Kadir, Nur Suhaila Idris, Siti Nurbaya Mohd Nawi
Older Adults with Hypertension: Prevalence of Falls and Their Associated Factors. International journal of environmental research and public health 18 (16) (2021)
Azidah Abdul Kadir, Norhayati Mohd Noor, Ahmad Faiq Mukhtar
Development and validation of the knowledge and attitude regarding childhood vaccination (KACV) questionnaire among healthcare workers: the Malay version. Human vaccines & immunotherapeutics (2021)